J

Johns Hopkins hospitals reduce sepsis mortality by 20% with AI early warning system detecting cases 6 hours sooner

“Johns Hopkins hospitals reduce sepsis mortality by 20% with AI early warning system detecting cases 6 hours sooner” documents a Clinical Decision Support deployment in Hospital & Health System at Johns Hopkins Medicine. hub.jhu.edu reports sepsis mortality reduction: 20%; this directory has not independently verified that result.

Maintained by Peter Korpak, Founder & Chief AnalystHow evidence is checked

Evidence at a glance

Evidence status:
Automated evidence gate passed
Deployment timeframe:
Not reported by source
Reported outcome metrics:
3 cited below
Directory entry published:
Source link checked:

The source-link check confirms reachability, not independent re-verification of every claim.

20%Sepsis Mortality Reduction
~6 hours earlier than traditional methodsEarly Detection Lead Time (Severe Sepsis)
~40% (vs. 2–5% for prior electronic tools)Detection Accuracy

Source-reported figures — cited source: hub.jhu.edu

The Challenge

Sepsis claims over 250,000 lives annually in the US and is notoriously difficult to detect early because its symptoms—fever, confusion—overlap with many other conditions. Traditional electronic detection tools caught fewer than half of sepsis cases and were accurate only 2–5% of the time, leading to frequent false alarms that eroded clinician trust and delayed intervention.

The Solution

The Targeted Real-Time Early Warning System (TREWS), developed at Johns Hopkins and commercialized by spin-off Bayesian Health, continuously scours EHR data, clinical notes, lab results, and patient history to flag sepsis risk and recommend treatment protocols such as antibiotic initiation. The system tracks patients from admission through discharge across department transitions, and was integrated with Epic and Cerner EHR platforms for broad deployability.

Results

Across a two-year study of 590,000 patients at five hospitals with more than 4,000 clinicians, the AI detected 82% of sepsis cases with ~40% accuracy—roughly 8× better than prior tools. In the most severe cases, the system identified sepsis an average of nearly six hours earlier than traditional methods. Patients treated using the system were 20% less likely to die from sepsis.

Key Takeaways

  • Site-adaptive ML that accounts for local patient population diversity and care delivery patterns is critical to achieving real-world accuracy and clinician adoption.
  • Integrating directly with major EHR platforms (Epic, Cerner) at deployment time removes a key adoption barrier for scaling to new hospitals.
  • Publishing outcomes in peer-reviewed journals (Nature Medicine, Nature Digital Medicine) with 590,000-patient validation establishes the credibility needed for clinical trust.

Share:

Details

Company Size
Enterprise
Evidence status
Automated evidence gate passed
Deployment timeframe
Not reported by source
Directory entry published
Source link checked

Cited source

hub.jhu.edu

Have a similar implementation?

Share your customer's AI results and link it to your vendor profile.

Submit a case study →